PRESS-RELEASE ·Filed Jun 12, 2026
Press release · Announcement
Actionable Insight • Neutral
Monitor for CE Mark approval decision or further regulatory updates; no immediate catalyst from this procedural filing.
Final — all horizons settled through T+60d
PFSA ▼ -88.98% at T+60d
NEUTRAL call -88.98% · α vs SPY -91.77% · entry $0.2242 → $0.0247
T+1d
+5.40%
call +5.40% · α +3.63%
$0.2363
settled 4mo ago
T+5d
-27.56%
call -27.56% · α -27.92%
$0.1624
settled 4mo ago
T+20d
-64.14%
call -64.14% · α -65.50%
$0.0804
settled 4mo ago
T+60d
-88.98%
call -88.98% · α -91.77%
$0.0247
settled 7w ago
Price Chart
Loading chart...
Executive Summary
Profusa announced submission of its response package to European Notified Body GMED for CE Mark certification of the Lumee Oxygen Platform. This is a procedural regulatory milestone with no financial data or assurance of outcome.
Key Facts
- Profusa submitted response package to GMED for CE Mark conformity assessment of the Lumee Oxygen Platform
- No financial figures, guidance, or approval timeline disclosed
- CE Mark review process remains ongoing with no assurance of timing or outcome
Financial Impact
No financial impact disclosed; regulatory step with uncertain commercial outcome
Risk Factors
- CE Mark approval not guaranteed and timing uncertain
- Company has $1M market cap and negative historical stock performance following prior filings
Market Snapshot
Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3311009 |
19 reports for PFSA
67% Hit rate @ T+5 Went positive at some point 7 of 9 best @ T+20▲ +74.77%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Press Release | $1.07 $1.02 | ▼ −4.67% | ▼ −3.66% | $0.7800 (−27.10%) |
Oct 15, 2026 11d ago | 8-K | $1.07 $1.02 | ▲ +4.67% | ▲ +3.66% | $0.7800 (+27.10%) |
Oct 9, 2026 17d ago | 8-K | $1.30 $0.9002 | ▲ +30.75% | ▲ +29.26% | $0.7800 (+40.00%) |
Oct 5, 2026 21d ago | 8-K | $1.75 $1.30 | ▼ −25.71% | ▼ −26.14% | $0.7800 (−55.43%) |
Sep 24, 2026 4w ago | Press Release | $3.03 $1.87 | ▼ −38.28% | ▼ −37.87% | $0.7800 (−74.26%) |
Sep 16, 2026 5w ago | 8-K | $1.78 $2.05 | ▼ −15.17% | ▼ −12.61% | $0.7800 (+56.18%) |
Sep 15, 2026 5w ago | 8-K | $1.83 $1.91 | ▲ +4.37% | ▲ +3.55% | $0.7800 (−57.38%) |
Sep 1, 2026 7w ago | 8-K | $2.88 $2.47 | ▲ +14.24% | ▲ +14.32% | $0.7800 (+72.92%) |
Aug 31, 2026 8w ago | 8-K | $3.00 $2.88 | ▼ −4.00% | ▼ −3.86% | $0.7800 (−74.00%) |
Aug 20, 2026 9w ago | 8-K | $7.57 $4.24 | ▲ +43.99% | ▲ +45.10% | $0.7800 (+89.70%) |
Showing 10 of 19
US Market Status
Market Closed — Opens in 6h 16m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers